SCHEMBL6016262

SCHEMBL6016262

CCOC(=O)CCc1n[nH]c2ccc(Nc3nc(Nc4cccc(O)c4)ncc3F)cc12

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SYK P43405 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6016537 0.94 SYK (0.63) SYK
SCHEMBL6016118 0.89 SYK (0.48) SYK
SCHEMBL6016309 0.89 SYK (0.56) SYK
SCHEMBL6016710 0.88 SYK (0.62) SYK
SCHEMBL6016290 0.88 SYK (0.47) SYK
SCHEMBL6016334 0.86 SYK (0.59) SYK
SCHEMBL6016391 0.86 SYK (0.59) SYK
SCHEMBL6016638 0.86 SYK (0.55) SYK
SCHEMBL6016430 0.85 SYK (0.55) SYK
SCHEMBL6016130 0.85 SYK (0.55) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471915-A4 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS INC (US) 2006-02-15 EP disclosed
EP-1471915-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Rigel Pharmaceuticals, Inc. (US) 2004-11-03 EP disclosed
WO-2003063794-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS, INC. (US) 2003-08-07 WO disclosed